Literature DB >> 25703423

Oxidized LDL attenuates protective autophagy and induces apoptotic cell death of endothelial cells: Role of oxidative stress and LOX-1 receptor expression.

Vincenzo Mollace1, Micaela Gliozzi2, Vincenzo Musolino2, Cristina Carresi2, Saverio Muscoli3, Rocco Mollace2, Annamaria Tavernese2, Santo Gratteri2, Ernesto Palma2, Chiara Morabito2, Cristiana Vitale4, Carolina Muscoli5, Massimo Fini4, Francesco Romeo3.   

Abstract

BACKGROUND: Overproduction of oxidized-low density lipoproteins (oxyLDLs) has been found to contribute in endothelial cell (EC) dysfunction thereby leading to atherosclerosis development and progression. In particular, oxyLDLs lead to apoptotic cell death of EC via oxidative stress production, mostly subsequent to the overexpression of the scavenger receptor LOX-1. Here, we hypothesize that LOX-1 expression in EC represents a crucial event which attenuates protective autophagic response, thereby enhancing programmed endothelial cell death. METHODS AND
RESULTS: Bovine aortic endothelial cells (BAECs) in culture were exposed to oxyLDL (1-100 μM). After 48 h incubation, oxyLDL produced pronounced malondialdehyde (MDA) elevation and apoptotic cell death of BAEC as detected by FACS analysis, an effect counteracted by antioxidant N-acetyl-cysteine (NAC) as well as by the NO-donor SNAP. OxyLDL-induced apoptotic cell death was also accompanied by reduced VEGF-dependent phosphorylation of constitutive NO synthase (cNOS) in BAEC and consistent attenuation of autophagic response as detected by the expression of Beclin-1 and LC3, two reliable biomarkers of autophagy. Moreover, silencing LOX-1 receptor significantly restored LC3 expression in oxyLDL-treated BAEC, thus suggesting a key role of LOX-1 overproduction in oxyLDL-induced endothelial dysfunction.
CONCLUSIONS: OxyLDL leads to impaired NO generation and apoptotic cell death in BAECs. This effect occurs via the overexpression of LOX-1 and subsequent attenuation of protective autophagic response thereby contributing to the pathophysiology of oxyLDL-induced endothelial dysfunction which characterizes early stages of atherosclerotic process.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  LOX-1; Oxidative stress; Oxidized-LDL; Protective autophagy

Mesh:

Substances:

Year:  2015        PMID: 25703423     DOI: 10.1016/j.ijcard.2015.02.007

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  22 in total

1.  The role of the lectin-like oxLDL receptor (LOX-1) in traffic-generated air pollution exposure-mediated alteration of the brain microvasculature in Apolipoprotein (Apo) E knockout mice.

Authors:  JoAnn Lucero; Usa Suwannasual; Lindsay M Herbert; Jacob D McDonald; Amie K Lund
Journal:  Inhal Toxicol       Date:  2017-08-17       Impact factor: 2.724

2.  Store-operated calcium entry-activated autophagy protects EPC proliferation via the CAMKK2-MTOR pathway in ox-LDL exposure.

Authors:  Jie Yang; Jie Yu; Dongdong Li; Sanjiu Yu; Jingbin Ke; Lianyou Wang; Yanwei Wang; Youzhu Qiu; Xubin Gao; Jihang Zhang; Lan Huang
Journal:  Autophagy       Date:  2016-10-28       Impact factor: 16.016

3.  The synergistic effect of Citrus bergamia and Cynara cardunculus extracts on vascular inflammation and oxidative stress in non-alcoholic fatty liver disease.

Authors:  Vincenzo Musolino; Micaela Gliozzi; Ezio Bombardelli; Saverio Nucera; Cristina Carresi; Jessica Maiuolo; Rocco Mollace; Sara Paone; Francesca Bosco; Federica Scarano; Miriam Scicchitano; Roberta Macrì; Stefano Ruga; Maria Caterina Zito; Ernesto Palma; Santo Gratteri; Monica Ragusa; Maurizio Volterrani; Massimo Fini; Vincenzo Mollace
Journal:  J Tradit Complement Med       Date:  2020-02-08

Review 4.  Redox signaling in cardiovascular pathophysiology: A focus on hydrogen peroxide and vascular smooth muscle cells.

Authors:  Chang Hyun Byon; Jack M Heath; Yabing Chen
Journal:  Redox Biol       Date:  2016-08-26       Impact factor: 11.799

Review 5.  Defective Autophagy in Atherosclerosis: To Die or to Senesce?

Authors:  Mandy O J Grootaert; Lynn Roth; Dorien M Schrijvers; Guido R Y De Meyer; Wim Martinet
Journal:  Oxid Med Cell Longev       Date:  2018-02-26       Impact factor: 6.543

6.  VLDL Induced Modulation of Nitric Oxide Signalling and Cell Redox Homeostasis in HUVEC.

Authors:  Maria Chiara Magnifico; Roxana Elena Oberkersch; Azzurra Mollo; Luca Giambelli; Yasmine Grooten; Paolo Sarti; Graciela Cristina Calabrese; Marzia Arese
Journal:  Oxid Med Cell Longev       Date:  2017-09-20       Impact factor: 6.543

7.  Curcumin accelerates reendothelialization and ameliorates intimal hyperplasia in balloon-injured rat carotid artery via the upregulation of endothelial cell autophagy.

Authors:  Dongdong Chen; Xiaoyang Tao; Yang Wang; Fengxuan Tian; Yongxin Wei; Guilin Chen; Haitao Shen; Zhong Wang; Zhengquan Yu; Haiying Li; Gang Chen
Journal:  Int J Mol Med       Date:  2015-10-09       Impact factor: 4.101

8.  Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis.

Authors:  Xianxian Wu; Haiying Zhang; Wei Qi; Ying Zhang; Jiamin Li; Zhange Li; Yuan Lin; Xue Bai; Xin Liu; Xiaohui Chen; Huan Yang; Chaoqian Xu; Yong Zhang; Baofeng Yang
Journal:  Cell Death Dis       Date:  2018-02-07       Impact factor: 8.469

9.  MicroRNA-98 rescues proliferation and alleviates ox-LDL-induced apoptosis in HUVECs by targeting LOX-1.

Authors:  Zhibo Chen; Mian Wang; Qiong He; Zilun Li; Yang Zhao; Wenjian Wang; Jieyi Ma; Yongxin Li; Guangqi Chang
Journal:  Exp Ther Med       Date:  2017-03-02       Impact factor: 2.447

10.  Pro-atherogenic mediators and subclinical atherogenesis are related to epicardial adipose tissue thickness in patients with cardiovascular risk.

Authors:  Juan A Peraza-Zaldívar; Juan A Suárez-Cuenca; Rocío Aceves-Millán; Carlos Ixcamparij-Rosales; Lilia Amezcua; Rebeca Pérez-Cabeza de Vaca; Nuria Guerrero-Celis; Alberto Melchor-López; Paul Mondragón-Terán; Sofía L Alcaráz-Estrada
Journal:  J Int Med Res       Date:  2016-08-07       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.